Información de la revista
Vol. 2. Núm. 6.
Páginas 289-293 (Noviembre - Diciembre 2006)
Vol. 2. Núm. 6.
Páginas 289-293 (Noviembre - Diciembre 2006)
Originales
Acceso a texto completo
Patrón de citocinas séricas en pacientes con artritis reumatoide de acuerdo a su reactividad al PPD
Pattern of serum cytokines in patients with rheumatoid artritis according to PPD reactivity
Visitas
10567
Darío Ponce de León Pandolfi
Autor para correspondencia
edacvas@terra.com.pe

Correspondencia: Dr. D. Ponce de León Pandolfi. Hospital Nacional Guillermo Almenara Irigoyen. Red Asistencial Almenara. EsSalud. Lima. Avda. Grau, 800. Lima 13. Perú.
, César Pastor Asurza, Yasmina Beraun, Eduardo Acevedo-Vásquez, Alfredo Sánchez-Torres, José Alfaro Lozano, Risto Perich Campos, Mariano Cucho Venegas, César Gutiérrez Villafuerte, César Sánchez Schwartz
Servicio de Reumatología. Hospital Nacional Guillermo Almenara Irigoyen-Red Asistencial Almenara. EsSalud. Lima. Perú
Este artículo ha recibido
Información del artículo
Resumen
Bibliografía
Descargar PDF
Estadísticas
Introducción

En un reciente estudio, se demostró una alta reactividad negativa al PPD o tuberculina en pacientes con artritis reumatoide (AR), (70%) comparado con controles (30%). Para determinar si esta alta reactividad negativa al PPD está asociada con un determinado patrón de citocinas, se compararon las concentraciones séricas de interleucina (IL)-2, IL-4, IL-6, IL-10, factor de necrosis tumoral (TNF)-α e interferón (IFN)-γ en pacientes con AR con reactividad positiva y negativa al PPD. Se analizó también la correlación entre las citocinas y la actividad de la AR.

Material y métodos

Se estudiaron 40 pacientes con AR y 21 individuos sanos. Se consideró reactividad positiva al PPD a una induración ≥ 5mm y reactividad negativa cuando es < 5 mm. La actividad de la AR se determinó según el DAS28. Las citocinas se determinaron por citometría de flujo utilizando el Kit Multiplex Cytometric Bead Array.

Resultados

De los pacientes con AR, 27 (67,5%) presentaron reactividad negativa al PPD y 13 (32,5%) reactividad positiva al PPD, similares en edad, sexo femenino y enfermedad activa. No se encontraron diferencias significativas en las citocinas entre los grupos con PPD positivo y PPD negativo. El IFN-γ (r = 0,433; p = 0,005) y la IL-6 (r = 0,325; p = 0,041) fueron las únicas que mostraron correlación positiva con la actividad de la enfermedad.

Conclusiones

No parece que haya diferencias en el patrón de citocinas séricas en los pacientes con reactividad negativa y positiva al PPD.

Key words:
Rheumatoid arthritis (RA)
PPD
Cytokines
Palabras clave:
Artritis reumatoide (AR)
PPD
Citocinas
Introduction

We demonstrated, in a recently published study, far more PPD negative reactivity among patients who had RA (70%) than among controls (30%). To evaluate the hypothesis that different response to PPD in RA patients is associated with different profiles of serum cytokines, we compared the serum levels of IL-2, IL-4, IL-6, IL-10, TNF alpha and IFN gamma from PPD negative and PPD positive RA patients. We also evaluated any correlations between serum cytokines and RA activity.

Material and methods

Forty RA patients and 21 controls were enrolled. Those with an induration < 5mm were considered as negative and those with ≥ 5mm as positive PPD. Disease activity was calculated using DAS28. Plasma levels of cytokines were determined using the multiplex BD TM Cytometric Bead Array Kit Assay.

Results

Of the RA patients, 27 (67.5%) had negative reaction to PPD and 13 (32.5%) a positive reaction to PPD. There was no statistical difference in sex profile, age or activity index between both negative and positive PPD RA patients. There was no significant difference in all the cytokines measured between PPD positive and PPD negative RA patients. Index activity show a positive correlation with IFN gamma (r = 0.433; p = 0.005) and IL-6 (r = 0.325;

p = 0.041) in RA patients.

Conclusions

Positive and negative tuberculin RA patients seem to show a similar cytokine serum profile.

El Texto completo está disponible en PDF
Bibliografía
[1.]
R. Barnetson, D. Gawkrodger, W. Britton.
Tuberculin-Type Hipersensitivity.
Immunology, pp. 25.5
[2.]
P. Emery, G.S. Panayi, A.M. Nouri.
Interleukin-2 reverses deficient cell-mediated immune responses in rheumatoid arthritis.
Clin Exp Immunol, 57 (1984), pp. 123-129
[3.]
G.H. Kingsley, C. Pitzalis, G.S. Panayi.
Abnormal lymphocyte reactivity to self major histocompatibility antigens in rheumatoid arthritis.
J Rheumatol, 14 (1987), pp. 667-673
[4.]
L. Paimela, E.A. Johansson-Stephansson, S. Koskimies, M. Leurisalo-Repo.
Depressed cutaneous cell mediated immunity in early rheumatoid arthritis.
Clin Exp Rheumatol, 8 (1990), pp. 433-437
[5.]
M.G. Helliwell, G.S. Panayi, A. Unger.
Delayed cutaneous hypersensitivity in rheumatoid arthritis: the influence of nutrition and drug therapy.
Clin Rheumatol, 3 (1984), pp. 39-43
[6.]
D. Ponce de León, E. Acevedo-Vásquez, A. Sánchez-Torres, M. Cucho, J. Alfaro, R. Perich, et al.
Attenuated response to purified protein derivative in patients with rheumatoid arthritis: study in a population with a high prevalence of tuberculosis.
Ann Rheum Dis, 64 (2005), pp. 1360-1361
[7.]
R. De Waal, J. Haanen, H.M. Spits.
Interleukin 10 and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen presenting capacity of monocytes via down regulation of class II major histocompatibility complex expression.
J Exp Med, 174 (1991), pp. 915-924
[8.]
A.E. Cope, M. Landei, N.R. Chu, et al.
Chronic exposure to TNF in vitro impairs the activation of T cells through the T cell receptor/CD3 complex; reversal in vivo by anti-TNF antibodies in patients with rheumatoid arthritis.
J Clin Invest, 94 (1994), pp. 749-755
[9.]
American Thoracic Society.
Targeted Tuberculin Testing and Treatment of Latent Tuberculosis Infection.
Am J Resp Crit Care Med, 161 (2000), pp. 221-247
[10.]
G.H. Kingsley, G.S. Panayi.
Mechanism of the deficient mononuclear cell response to tuberculin PPD in rheumatoid arthritis.
Clin Rheumatol, 5 (1986), pp. 149-152
[11.]
V.M. Corrigal, G. Garyfallos, G.S. Panayi.
The relative proportions of secreted interleukin 2 and interleukin 10 determine the magnitude of rheumatoid arthritis T-cell proliferation to the recall antigen tuberculin purified protein derivative.
Rheumatology, 38 (1999), pp. 1203-1207
[12.]
P.D. Katsikis, C. Chu, F.M. Brennan, et al.
Immunoregulatory role of interleukin 10 in rheumatoid arthritis.
J Exp Med, 179 (1994), pp. 1517-1522
[13.]
K. Yudoh, H. Matsuno, F. Nakazawa, et al.
Reduced expression of the regulatory CD4 + T cell subset is related to Th1/Th2 balance and disease severity in rheumatoid arthritis.
[14.]
M. Al-Janadi, S. Al-Balla, A. Al-Dalaan, S. Raziuddin.
Cytokine production by helper T cell populations from the synovial fluid and peripheral blood in patients with rheumatoid arthritis.
J Rheumatol, 20 (1993), pp. 1647-1653
[15.]
J. Gratacós, A. Collado, X. Filella, R. Sanmarti, J. Cañete, J. Llena, et al.
Serum cytokines (Il-6,TNF-α, IL-1 and IFN-γ) in ankylosing spondylitis: a close correlation between serum IL-6 and disease activity and severity.
Br J Rheum, 33 (1994), pp. 927-933
[16.]
I. Holt, R.G. Cooper, S.J. Hopkins.
Relationships between local inflammation, IL-6 concentration and the acute phase protein response in arthritis patients.
Eur J Clin Invest, 21 (1991), pp. 479-484
[17.]
B. Smith, M. Haynes.
Rheumatoid Arthritis-A Molecular Understanding.
Ann Internal Med, 136 (2002), pp. 908-922
[18.]
M. Brozik, I. Rosztoczy, K. Meretey, et al.
IL-6 levels in synovial fluids of patients with different arthritides: Correlation with local IgM rheumatoid factor and systemic acute phase protein production.
J Rheumatol, 19 (1992), pp. 63-68
Copyright © 2006. Elsevier España S.L. Barcelona
Idiomas
Reumatología Clínica
Opciones de artículo
Herramientas
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?